Wilms Tumor-1 protein
Showing 1 - 25 of >10,000
Esophageal Cancer, Pancreas Cancer, Ovarian Cancer Trial in Edegem (IL15-transpresenting WT1-targeted Dendritic Cell Vaccine)
Not yet recruiting
- Esophageal Cancer
- +3 more
- IL15-transpresenting WT1-targeted Dendritic Cell Vaccine
-
Edegem, BelgiumAntwerp University Hospital
Jul 19, 2023
Mesothelioma, Pleural Mesothelioma, Wilms Tumor Trial in United States (Galinpepimut-S, Nivolumab, Sargramostim)
Active, not recruiting
- Mesothelioma
- +2 more
- Galinpepimut-S
- +2 more
-
Basking Ridge, New Jersey
- +5 more
Nov 23, 2022
Familial Investigations of Childhood Cancer Predisposition
Recruiting
- Acute Leukemia
- +45 more
-
Memphis, TennesseeSt. Jude Children's Research Hospital
May 11, 2022
International PPB/DICER1 Registry
Recruiting
- Pleuropulmonary Blastoma
- +14 more
-
Minneapolis, MinnesotaChildren's Minnesota
Aug 16, 2022
Pediatric Solid Tumor, Germ Cell Tumor, Retinoblastoma Trial in Seattle (second generation 4-1BB? EGFR806-EGFRt, second
Recruiting
- Pediatric Solid Tumor
- +15 more
- second generation 4-1BBζ EGFR806-EGFRt
- second generation 4-1BBζ EGFR806-EGFRt and a second generation 4 1BBζ CD19-Her2tG
-
Seattle, WashingtonSeattle Children's Hospital
May 2, 2022
GCF PLAP-1, Sclerostin and TNF-a Levels in Periodontitis
Completed
- Periodontitis
- Periodontal clinical measurements and GCF sampling
-
Aydın, TurkeyAdnan Menderes University, Faculty of Dentistry, Department of P
Dec 8, 2022
Advanced Solid Tumor, Refractory Non-Hodgkin Lymphoma Trial (HCB101)
Not yet recruiting
- Advanced Solid Tumor
- Refractory Non-Hodgkin Lymphoma
- (no location specified)
May 28, 2023
Lymphoma, Childhood Lymphoma, Solid Tumor Trial in Charlottesville (Genistein, Placebo)
Terminated
- Lymphoma
- +15 more
- Genistein
- Placebo
-
Charlottesville, VirginiaUniversity of Virginia
Feb 8, 2022
ATM Alterations by Next-Generation Sequencing and ATM
Completed
- Solid Tumor, Unspecified, Adult
- Determination of ATM alteration status.
-
Oklahoma City, Oklahoma
- +2 more
Jul 29, 2022
Hematologic Malignancy Trial in Tianjin (IMM01)
Terminated
- Hematologic Malignancy
-
Tianjin, Tianjin, ChinaChinese Academy of Medical Sciences and Peking Union Medical Col
May 5, 2023
Pleuropulmonary Blastoma, Recurrent Malignant Peripheral Nerve Sheath Tumor, Recurrent Neuroblastoma Trial in United States
Completed
- Pleuropulmonary Blastoma
- +5 more
- Laboratory Biomarker Analysis
- +2 more
-
Birmingham, Alabama
- +68 more
Jan 4, 2022
Adult Kidney Wilms Tumor, Beckwith-Wiedemann Syndrome, Childhood Kidney Wilms Tumor Trial in Worldwide (biological, drug,
Active, not recruiting
- Adult Kidney Wilms Tumor
- +10 more
- Dactinomycin
- +4 more
-
Birmingham, Alabama
- +168 more
Mar 23, 2022
ctDNA Methylation for Detecting Ovarian Cancer
Recruiting
- Epithelial Ovarian Cancer
- +8 more
- Methylation assay
-
Beijing, Beijing, ChinaLei Li
Mar 24, 2023
HLA-A2 Positive Cells Present, Refractory Melanoma Trial in Buffalo (Alpha-type-1 Polarized Dendritic Cells, Celecoxib, PD-1
Recruiting
- HLA-A2 Positive Cells Present
- Refractory Melanoma
- Alpha-type-1 Polarized Dendritic Cells
- +5 more
-
Buffalo, New YorkRoswell Park Cancer Institute
Dec 12, 2022
ctDNA Methylation for Epithelial Ovarian Cancer
Recruiting
- Epithelial Ovarian Cancer
- +7 more
- CDO1 and HOXA9 methylation assay
-
Beijing, Beijing, ChinaLei Li
Mar 24, 2023
Advanced Malignant Solid Tumor Trial in France, Netherlands (MP0317, a tri-specific fibroblast activation protein (FAP) x CD40
Recruiting
- Advanced Malignant Solid Tumor
- MP0317, a tri-specific fibroblast activation protein (FAP) x CD40 DARPin® drug candidate
-
Lyon, Cedex 08, France
- +3 more
Nov 4, 2022
Solid Tumor, Unspecified, Adult Trial in Singapore (177Lu-LNC1004 Injection group 1 radionuclide therapy, 177Lu-LNC1004
Not yet recruiting
- Solid Tumor, Unspecified, Adult
- 177Lu-LNC1004 Injection group 1 radionuclide therapy
- +3 more
-
Singapore, SingaporeNational University Cancer Institute, Singapore National Univers
Feb 1, 2023
Colorectal Carcinoma, Endometrial Carcinoma, Melanoma Trial in United States (Tegavivint)
Recruiting
- Colorectal Carcinoma
- +21 more
- Dual X-ray Absorptiometry
- +2 more
-
Birmingham, Alabama
- +18 more
Jan 30, 2023